XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding XBiotech Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 45 | 41 | −4 |
| Shares | 3.06M | 2.76M | −302.3K (−9.9%) |
| Value | $11.1M | $9.68M | −$1.40M (−12.6%) |
New holders (1)
Institutions that held XBiotech Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 11,725 | $41.2K | 0.00% |
Sold out (5)
Institutions that held XBiotech Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| RBF Capital, LLC | 23,172 | $84.0K |
| Qube Research & Technologies Ltd | 12,591 | $46.0K |
| Jane Street Group, LLC | 10,439 | $38.0K |
| ETF Managers Group, LLC | 8,982 | $33.0K |
| Capital Advisors, Ltd. LLC | 209 | $1.00K |